Frank L. Douglas

From Wikipedia, the free encyclopedia

Frank L. Douglas M.D., Ph.D. is a Guyanese American medical doctor.

Douglas graduated from Lehigh University, received his M.D. and Ph.D. degrees from Cornell University, completed an internship and residency in internal medicine at Johns Hopkins Medical Institution, and a fellowship in neuroendocrinology at the National Institutes of Health. Douglas taught clinical pharmacology at the Pritzker School of Medicine before becoming a professor of practice at MIT and establishing the Center for Biomedical Innovation Management.^[1]

Douglas is currently president and CEO of Austen BioInnovation Institue in Akron and currently sits on the Board of Trustees at Lehigh University and Johann Wolfgang Goethe University Frankfurt am Main as well as the board of directors at the Kauffman Foundation, Battel, NitroMed, Gene Logic, and Altanos Pharmaceuticals Holding.

External links

MIT Center for Biomedical Innovation biography
Discrimination in academia – The Scientist article by Douglas

References

↑ "People - Frank L. Douglas, Ph.D., M.D.". MIT Center for Biomedical Innovation. Retrieved 2008-08-12.

Persondata
Name	Douglas, Frank L.
Alternative names
Short description
Date of birth
Place of birth
Date of death
Place of death

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.